ArticleMolecular cancer2017

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.

Sherif Abdelaziz Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.